Show an ad over header. AMP

I am the FIRST

Trump adopts Peter Navarro's "deep state" rhetoric about the FDA

Senior health officials in the Trump administration were taken aback last Monday when the president's trade adviser, Peter Navarro, accused them of being part of the "Deep State" during a meeting that was supposed to be about COVID-19 and the Strategic National Stockpile.

Why it matters: Five days after Navarro's private comments toward the FDA, the president echoed Navarro's sentiments with a pair of Saturday morning tweets and tagged Stephen Hahn, the head of the Food and Drug Administration.


  • "The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics," the president tweeted. "Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!"
  • Trump then attacked the FDA for revoking its emergency use authorization "of hydroxychloroquine and chloroquine for treating COVID-19 amid growing evidence that the drugs are 'unlikely to be effective' in treating the coronavirus."

Behind the scenes: According to two sources in the Monday meeting, Navarro had aggressively confronted FDA officials, saying, "You are all Deep State and you need to get on Trump Time." (That's the expression Navarro uses to describe the speed that he says Trump demands.)

  • Sources familiar with the situation said Navarro has been venting at the FDA for weeks at what he perceives as its slowness to approve therapeutics to fight COVID-19 and help the U.S. "bring our medical supply chain home."
  • Navarro has argued that the FDA's slowness has cost lives during a pandemic.
  • A third senior administration official said Navarro — a fervent proponent of hydroxychloroquine — remained angry at the FDA for saying the drug didn't work against COVID-19.

Senior health officials counter that the FDA needs to follow a rigorous process to ensure that the public can trust that they are operating by the book — and by the science, free from political pressure — and that whatever therapeutics and vaccines the FDA authorizes are safe for use.

  • Asked about the reaction in the meeting to Navarro's comments, a source familiar said, "People just listened. A lot of the quote 'Deep State' people are shocked. But Navarro is Navarro."
  • Navarro declined to comment.

What's next: Late Saturday, White House press secretary Kayleigh McEnany tweeted, "News conference with President @realDonaldTrump at 6 pm tomorrow concerning a major therapeutic breakthrough on the China Virus. Secretary Azar and Dr. Hahn will be in attendance."

  • Trump tweeted today, "Important White House News Conference at 5:30 (sharp) today. Very good news!"
  • The Washington Post reports that Trump "will announce the emergency authorization of convalescent plasma for COVID-19, a treatment that already has been given to more than 70,000 patients, according to officials familiar with the decision."

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Scoop: Amazon quietly getting into live audio business

Amazon is investing heavily in a new live audio feature that's similar to other live audio offerings like Clubhouse, Twitter Spaces and Spotify's new live audio platform, sources tell Axios.

Why it matters: As with Amazon's efforts in podcasting and music subscriptions, the company sees live audio as a way to bolster the types of content it can offer through its voice assistant, Alexa, and its smart speaker products.

Keep reading... Show less

Hurricane Ida exposes America's precarious energy infrastructure

The powerful hurricane that plunged New Orleans into darkness for what could be weeks is the latest sign that U.S. power systems are not ready for a warmer, more volatile world.

The big picture: “Our current infrastructure is not adequate when it comes to these kinds of weather extremes,” Joshua Rhodes, a University of Texas energy expert, tells Axios.

Keep reading... Show less

"We must go further": 70% of adults in European Union are fully vaccinated

About 70% of adults in the European Union are fully vaccinated against COVID-19, Ursula von der Leyen, the president of the European Commission, said Tuesday.

Why it matters: The milestone makes the E.U. one of the world's leaders in inoculations, after an initially lagging vaccine campaign, the New York Times notes.

Keep reading... Show less

What Elizabeth Holmes jurors will be asked ahead of fraud trial

Jury selection begins today in USA v. Elizabeth Holmes, with the actual jury trial to get underway on Sept. 8.

Why it matters: Theranos was the biggest fraud in Silicon Valley history, putting both hundreds of millions of dollars and thousands of patients' health at risk.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories